Harvey I Miller

Title: Harvey I Miller: Innovator in Enzymatic Research

Introduction

Harvey I Miller is a notable inventor based in Pleasant Hill, CA, with a significant contribution to the field of enzymatic research. He holds five patents that showcase his innovative work in biotechnology, particularly in the area of neuraminidase enzymes.

Latest Patents

Miller's latest patents include groundbreaking work on polynucleotides encoding α2-3 neuraminidase. This invention provides polynucleotide sequences that encode enzymes with α2-3 neuraminidase activity, particularly those produced by the bacteria Streptococcus pneumoniae. His research also describes recombinant DNA expression methods for these enzymes, including the use of recombinant host cells and genetic constructions. Additionally, he has developed a purified enzyme with α2-3 neuraminidase activity isolated from S. pneumoniae cultures. Another significant patent involves a balanced inducible transcription system that facilitates the expression of polypeptides incompatible with recombinant host cells. This system has enabled the production of mature, unglycosylated human tissue plasminogen activator in prokaryotes, achieving commercially significant amounts without the need for in vitro renaturation and processing.

Career Highlights

Throughout his career, Miller has worked with prominent companies such as Genentech, Inc. and Glyko, Inc. His contributions to these organizations have been instrumental in advancing research and development in biotechnology.

Collaborations

Miller has collaborated with notable colleagues, including Chung-Cheng Liu and Stephen P Anderson, further enhancing the impact of his work in the field.

Conclusion

Harvey I Miller's innovative research and patents have significantly advanced the understanding and application of enzymatic processes in biotechnology. His work continues to influence the field and inspire future innovations.